Preeclampsia: multiple approaches for a multifactorial disease

KA Pennington, JM Schlitt, DL Jackson… - Disease models & …, 2012 - journals.biologists.com
Preeclampsia is a pregnancy-specific disorder characterized by hypertension and excess
protein excretion in the urine. It is an important cause of maternal and fetal morbidity and …

[HTML][HTML] FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal …

N Melamed, A Baschat, Y Yinon… - … of Gynaecology and …, 2021 - ncbi.nlm.nih.gov
Fetal growth restriction (FGR) is defined as the failure of the fetus to meet its growth potential
due to a pathological factor, most commonly placental dysfunction. Worldwide, FGR is a …

Effects and safety of magnesium sulfate on neuroprotection: a meta-analysis based on PRISMA guidelines

X Zeng, Y Xue, Q Tian, R Sun, R An - Medicine, 2016 - journals.lww.com
Effects and Safety of Magnesium Sulfate on Neuroprotection:... : Medicine Effects and Safety of
Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines …

Tocolysis for acute preterm labor: does anything work

K Haram, JHS Mortensen… - The Journal of Maternal …, 2015 - Taylor & Francis
The central rationale of tocolysis for preterm labor (PTL) is to delay delivery for at least 48 h
to allow for transfer of the mother to a tertiary facility and for corticosteroids to induce …

Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth

E Bain, P Middleton… - Cochrane Database of …, 2012 - cochranelibrary.com
Background The effectiveness of antenatal magnesium sulphate for neuroprotection of the
fetus, infant, and child prior to very preterm birth, when given to women considered at risk of …

Prevention of preterm labour: 2011 update on tocolysis

C Hubinont, F Debiève - Journal of pregnancy, 2011 - Wiley Online Library
The aim of this paper is to review available data about drugs for preventing preterm labour.
Tocolytic therapy includes β adrenergic receptor agonists, NO donors, magnesium sulphate …

Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates

H Suzuki‐Kakisaka, J Sugimoto… - American journal of …, 2013 - Wiley Online Library
Problem Magnesium sulfate (MgSO4) exposure reduces the risk of cerebral palsy. As
neonatal inflammatory cytokine levels strongly correlate with neurologic outcome, we …

Surgical airway

SA Patel, TK Meyer - International journal of critical illness and …, 2014 - journals.lww.com
Close to 3% of all intubation attempts are considered difficult airways, for which a plan for a
surgical airway should be considered. Our article provides an overview of the different types …

Postconcussion syndrome: a review of pathophysiology and potential nonpharmacological approaches to treatment

JC Maroon, DB LePere, RL Blaylock… - The Physician and …, 2012 - Taylor & Francis
The incidence of all-cause concussions in the United States is estimated to range from 1.6 to
3.8 million annually, with the reported number of sport-or recreation-related concussions …

Magnesium sulfate and novel therapies to promote neuroprotection

RA Jameson, HB Bernstein - Clinics in perinatology, 2019 - perinatology.theclinics.com
Preterm delivery (PTD) is a major cause of neonatal morbidity and mortality, with surviving
infants at risk for long-term neurologic sequelae. Although any birth occurring before the …